Healthcare Resource Consumption and Related Costs of Patients Estimated with Treatment-Resistant Depression in Italy

A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients

(2020) Gang Li et al.   PLoS One

Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorder

(2020) Maryia Zhdanava et al.   CURRENT MEDICAL RESEARCH AND OPINION

Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: Economic burden and healthcare resource utilization

(2020) Roger S. McIntyre et al.   JOURNAL OF AFFECTIVE DISORDERS

The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study

(2019) Dena H. Jaffe et al.   BMC Psychiatry

The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature

(2018) Karissa Johnston et al.   JOURNAL OF AFFECTIVE DISORDERS

Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression

(2018) Tony B. Amos et al.   JOURNAL OF CLINICAL PSYCHIATRY

Direct and indirect costs of employees with treatment-resistant and non-treatment-resistant major depressive disorder

(2010) Jasmina I. Ivanova et al.   CURRENT MEDICAL RESEARCH AND OPINION